leadXpro and Astex enter partnership on membrane protein structure research
Astex Pharmaceuticals partners with leadXpro to facilitate structure-based drug discovery for membrane protein targets by cryo-Electron Microscopy
news
Latest developments, partnerships and scientific breakthroughs
leadXpro licenses cryoSPARC™ software
By licensing cryosparc software and upgrading of its in-house computing capacity, leadXpro enhances its ability for high resolution structure determination of membrane protein drug targets by single particle cryo-Electron Microscopy (cryo-EM)
Symposium on Drug Discovery @ SwissFEL
The registration for the International Symposium on Structure Biology for Drug Discovery@SwissFEL on June 25-27, 2019 in Villigen, Switzerland is now open.
Collaboration with Sanofi on cryo-EM based structure research
leadXpro and Sanofi collaborate for cryo-EM structure project
First biomolecular structure experiment at SwissFEL
leadXpro determined the first protein structure at the Swiss Free Electron Laser (SwissFEL) facilities.
Collaboration with the University of Zürich on membrane protein targeted sybodies
leadXpro AG and the University of Zurich (UZH) collaborate to generate sybodies as molecular discovery tools, therapeutic lead compounds and diagnostic reagents against disease-relevant membrane protein targets.
Collaboration with InterAx on new immune oncology drugs
leadXpro AG and InterAx Biotech AG, join forces to discover and optimize new drug lead molecules targeting G-protein coupled receptors.
CTI grants leadXpro startup label
The Swiss Commission for Technology and Innovation CTI awards leadXpro the CTI startup label.